Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide

Gynecologic Oncology

Volumn 140, Issue 2, 2016, Pages 359-368

  Huffman, Laura B ^a   Hartenbach, Ellen M ^a   Carter, Jeanne ^b   Rash, Joanne K ^a   Kushner, David M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Female sexual dysfunction; Gynecologic cancer; Quality of life; Sexual health

Indexed keywords

LUBRICATING AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; COGNITIVE THERAPY; DYSPAREUNIA; ENDOMETRIUM CANCER; FEMALE; FEMALE GENITAL PAIN; FEMALE GENITAL TRACT CANCER; FEMALE SEXUAL DYSFUNCTION; GENITO PELVIC PAIN; HEALTH CARE PERSONNEL; HUMAN; HUMIDIFIER; MEDLINE; MORBIDITY; ORGASM DISORDER; OVARY CANCER; PELVIS FLOOR; PENETRATION DISORDER; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SEXUAL HEALTH; STENOSIS; UROLOGICAL DILATOR; UTERINE CERVIX CANCER; VAGINA ATROPHY; VAGINA PAIN; VULVA CANCER; GENITAL NEOPLASMS, FEMALE; PATHOPHYSIOLOGY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84947604278     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.11.010     Document Type: Review

References (120)

1. N. Howlander, and et al. SEER Cancer Statistics Review 1975-2012 2015 National Cancer Institute
2. A.C. Society Cancer Treatment and Survivorship Facts & Figures 2014-2015 2014 American Cancer Society Atlanta
3. Research, D.o.R.H.a. W.H. Organization Developing sexual health programmes 2010 WHO Press Geneva, Switzerland
4. E.O. Laumann, P.A.; and R.C. Rosen Sexual dysfunction in the United States: prevalence and predictors JAMA 281 6 1999 537 544
5. S.T. Lindau, and et al. A study of sexuality and health among older adults in the United States N. Engl. J. Med. 357 8 2007 762 774
6. N. Onujiogu, and et al. Survivors of endometrial cancer: who is at risk for sexual dysfunction? Gynecol. Oncol. 123 2 2011 356 359
7. A.O. Levin, and et al. Sexual morbidity associated with poorer psychological adjustment among gynecological cancer survivors Int. J. Gynecol. Cancer 20 3 2010 461 470
8. L.D. Flay, and J.H. Matthews Effects of radiotherapy and surgery on sexual function of women treated for cervical cancer Int. J. Radiat. Oncol. Biol. Phys. 31 2 1995 399 404
9. J. Carter, and et al. A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer Gynecol. Oncol. 119 2 2010 358 365
10. S.T. Lindau, N. Gavrilova, and D. Anderson Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms Gynecol. Oncol. 106 2 2007 413 418
11. M.S. Green, and et al. Sexual dysfunction following vulvectomy Gynecol. Oncol. 77 1 2000 73 77
12. E.K. Hill, and et al. Assessing gynecologic and breast cancer survivors' sexual health care needs Cancer 117 12 2011 2643 2651
13. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J. Clin. 65 1 2015 5 29
14. J.F. Boggess, and et al. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy Am. J. Obstet. Gynecol. 199 4 2008 360 e1-9
15. J.L. Walker, and et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study LAP2 J. Clin. Oncol. 27 32 2009 5331 5336
16. J.L. Walker, and et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group LAP2 study J. Clin. Oncol. 30 7 2012 695 700
17. L. Aerts, and et al. Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study J. Sex. Med. 12 1 2015 198 209
18. R.A. Nout, and et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
19. R.A. Nout, and et al. Five-year quality of life of endometrial cancer patients treated in the randomised post operative radiation therapy in endometrial cancer (PORTEC-2) trial and comparison with norm data Eur. J. Cancer 48 11 2012 1638 1648
20. M. Becker, and et al. Quality of life and sexual functioning in endometrial cancer survivors Gynecol. Oncol. 121 1 2011 169 173
21. A.M. Quick, and et al. Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma Int. J. Gynecol. Cancer 22 4 2012 703 708
22. S. Damast, and et al. Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 84 2 2012 e187 e193
23. D. Nunns, and et al. The morbidity of surgery and adjuvant radiotherapy in the management of endometrial cancer Int. J. Gynecol. Cancer 10 3 2000 233 238
24. E.R. Greimel, and et al. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study Psychooncology 18 5 2009 476 482
25. P.T. Jensen, and et al. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study Cancer 100 1 2004 97 106
26. Q.D. Pieterse, and et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study Int. J. Gynecol. Cancer 23 9 2013 1717 1725
27. Q.D. Pieterse, and et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer Int. J. Gynecol. Cancer 16 2006 1119 1129
28. C.P. Maas, and et al. Objective assessment of sexual arousal in women with a history of hysterectomy BJOG 111 5 2004 456 462
29. T. Song, and et al. Sexual function after surgery for early-stage cervical cancer: is there a difference in it according to the extent of surgical radicality? J. Sex. Med. 9 6 2012 1697 1704
30. L. Aerts, and et al. Long-term sexual functioning in women after surgical treatment of cervical cancer stages IA to IB: a prospective controlled study Int. J. Gynecol. Cancer 24 8 2014 1527 1534
31. C.D. de Kroon, and et al. Nerve sparing in radical surgery for early-stage cervical cancer: yes we should! Int. J. Gynecol. Cancer 20 11 Suppl. 2 2010 S39 S41
32. M. Ceccaroni, and et al. Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy: A multicenter comparative study Anticancer Res. 32 2012 581 588
33. A.F. Burnett, and et al. Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma Gynecol. Oncol. 88 3 2003 419 423
34. J.P. Diaz, and et al. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma Gynecol. Oncol. 111 2 2008 255 260
35. J.H. Shepherd, and et al. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women BJOG 113 6 2006 719 724
36. M.H. Einstein, and et al. Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes Gynecol. Oncol. 112 1 2009 73 77
37. L.P. Froeding, and et al. Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study J. Sex. Med. 11 2 2014 595 604
38. A. Katz, and et al. Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer Int. J. Gynecol. Cancer 11 2001 234 235
39. L.R. Schover, M. Fife, and D. Gershenson Sexual dysfunction and treatment for early stage cercvial cancer Cancer 63 1989 204 212
40. K. Bergmark, and et al. Vaginal changes and sexuality in women with a history of cervical cancer N. Engl. J. Med. 340 18 1999 1383 1389
41. A.H. Brand, C.A. Bull, and B. Cakir Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix Int. J. Gynecol. Cancer 16 1 2006 288 293
42. D.W. Bruner, and et al. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial cancer Int. J. Radiat. Oncol. Biol. Phys. 27 1993 825 830
43. M. Frumovitz, and et al. Quality of life and sexual functioning in cervical cancer survivors J. Clin. Oncol. 23 30 2005 7428 7436
44. G. Mantegna, and et al. Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis BMC Cancer 13 2013 127
45. P.T. Jensen, and et al. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer Int. J. Radiat. Oncol. Biol. Phys. 56 4 2003 937 949
46. C. Hughes, and et al. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause Gynecol. Oncol. 40 1991 42 45
47. L.R. Schover Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility J. Clin. Oncol. 26 5 2008 753 758
48. M.L. Krychman, and et al. Sexual oncology: sexual health issues in women with cancer Oncology 71 1-2 2006 18 25
49. A.H. Liavaag, and et al. A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach Gynecol. Oncol. 108 2 2008 348 354
50. D.E. Stewart, and et al. «What doesn't kill you makes you stronger»: an ovarian cancer survivor survey Gynecol. Oncol. 83 3 2001 537 542
51. L.B. Wenzel, and et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study Psychooncology 11 2 2002 142 153
52. A.B. Kornblith, and et al. Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease J. Psychosoc. Oncol. 28 5 2010 451 469
53. M.L. Stead, and et al. Psychosexual function and impact of gynaecological cancer Best Pract. Res. Clin. Obstet. Gynaecol. 21 2 2007 309 320
54. C.L. Carmack Taylor, and et al. Predictors of sexual functioning in ovarian cancer patients J. Clin. Oncol. 22 5 2004 881 889
55. D. Buković, and et al. Sexual functioning and body image of patients treated for ovarian cancer Sex. Disabil. 26 2 2008 63 73
56. D.M. Gershenson, and et al. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study J. Clin. Oncol. 25 19 2007 2792 2797
57. M. Hampl, and et al. New aspects of vulvar cancer: changes in localization and age of onset Gynecol. Oncol. 109 3 2008 340 345
58. E. Joura, A. Losch, and M. Haider-Angeler Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women J. Reprod. Med. 45 2000 613 615 (2000)
59. F.B. Stehman, and K.Y. Look Carcinoma of the vulva Obstet. Gynecol. 107 3 2006 719 733
60. H. NF, and et al. Radical vulvecotmy and bilateral inguinal lymphadenectomy through separate groin incisions Obstet. Gynecol. 58 1981 574 579
61. S.C. Ballon, and E.J. Lamb Separate inguinal incisions in the treatment of carcinoma of the vulva Surg. Gynecol. Obstet. 140 1 1975 81 84
62. S. FB, and et al. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: A prospective study of the gynecologic oncology group Obstet. Gynecol. 79 1992 490 497
63. C.F. Levenback, and et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study J. Clin. Oncol. 30 31 2012 3786 3791
64. E.L. Barlow, and et al. Sexuality and body image following treatment for early-stage vulvar cancer: a qualitative study J. Adv. Nurs. 70 8 2014 1856 1866
65. L. Aerts, and et al. Psychologic, relational, and sexual functioning in women after surgical treatment of vulvar malignancy: a prospective controlled study Int. J. Gynecol. Cancer 24 2 2014 372 380
66. M. Janda, and et al. Vulvar cancer patients' quality of life: a qualitative assessment Int. J. Gynecol. Cancer 14 2004 875 881
67. W. Weijmar Schulz, and et al. Psychosexual functioning after the treatment of cancer of the vulva Cancer 66 1990 402 407
68. V. Gunther, and et al. Impact of radical operative treatment on the quality of life in women with vulvar cancer-a retrospective study Eur. J. Surg. Oncol. 40 7 2014 875 882
69. W.M. Likes, and et al. Correlates of sexual function following vulvar excision Gynecol. Oncol. 105 3 2007 600 603
70. M.H. Hazewinkel, and et al. Long-term sexual function in survivors of vulvar cancer: a cross-sectional study Gynecol. Oncol. 126 1 2012 87 92
71. K.N. Gaarenstroom, and et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions Int. J. Gynecol. Cancer 13 2003 522 527
72. A.P. de Melo Ferreira, and et al. Quality of life in women with vulvar cancer submitted to surgical treatment: a comparative study Eur. J. Obstet. Gynecol. Reprod. Biol. 165 1 2012 91 95
73. D.M. Forner, R. Dakhil, and B. Lampe Quality of life and sexual function after surgery in early stage vulvar cancer Eur. J. Surg. Oncol. 41 1 2015 40 45
74. C. Denlinger, and et al. Survivorship: sexual dysfunction (female), version 1.2013, clinical guidelines in oncology J. Natl. Cancer Inst. 12 2014 184 192
75. D. Hatzichristou, and et al. Recommendations for the clinical evaluation of men and women with sexual dysfunction J. Sex. Med. 7 1 Pt 2 2010 337 348
76. K.E. Flynn, and et al. Development and Validation of a Single-Item Screener for Self-Reporting Sexual Problems in U.S. Adults J. Gen. Intern. Med. 2015
77. K.E. Flynn, and et al. Construct validity of the PROMIS(R) sexual function and satisfaction measures in patients with cancer Health Qual. Life Outcomes 11 2013 40
78. R.E. Baser, Y. Li, and J. Carter Psychometric validation of the female sexual function index (FSFI) in cancer survivors Cancer 118 18 2012 4606 4618
79. H.K. Haefner Critique of new gynecologic surgical procedures: surgery for vulvar vestibulitis Clin. Obstet. Gynecol. 43 3 2000 689 700
80. S.L. Bober, and V.S. Varela Sexuality in adult cancer survivors: challenges and intervention J. Clin. Oncol. 30 30 2012 3712 3719
81. A.P. Association Diagnostic and Statistical Manual of Mental Disorders: DSM-5 5th edition 2013 American Psychiatric Publishing Washington D.C. 970
82. R. Basson Sexual desires and arousal disorders in women N. Engl. J. Med. 354 14 2006 1497 1506
83. R.H.W. van Lunsen, and E. Laan Genital vascular responsiveness and sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies Menopause 11 2004 741 748 (Supplement)
84. L.A. Brotto, and et al. Women's sexual desire and arousal disorders J Sex Med 7 1 Pt 2 2010 586 614
85. L.A. Brotto, and et al. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer Gynecol. Oncol. 125 2 2012 320 325
86. FDA Joint Meeting of Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women NDA 022526. Advisory Committee Briefing Document 2015
87. L.R. Derogatis, and et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study J. Sex. Med. 9 4 2012 1074 1085
88. M. Katz, and et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial J. Sex. Med. 10 7 2013 1807 1815
89. J. Thorp, and et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study J. Sex. Med. 9 3 2012 793 804
90. J.A. Simon, and et al. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial Menopause 21 6 2014 633 640
91. E. Laan, and et al. Standard operating procedures for female orgasmic disorder: consensus of the international society for sexual medicine J. Sex. Med. 10 1 2013 74 82
92. C.M. Meston, and et al. Disorders of orgasm in women J. Sex. Med. 1 1 2004 66 68
93. J.L. Shifren, and et al. Sexual problems and distress in United States women: prevalence and correlates Obstet. Gynecol. 112 5 2008 970 978
94. A.L. Montejo-Gonzalez, and et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients J. Sex Marital Ther. 23 3 1997 176 194
95. E. Haberfellner, and H. Rittmannsberger Spontaneous remission of SSRI-induced orgasm delay Pharmacopsychiatry 37 2004 127 130
96. U. Werneke, S. Northey, and D. Bhugra Antidepressants and sexual dysfunction Acta Psychiatr. Scand. 114 6 2006 384 397
97. H. Nurnberg, and et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunct: A randomized controlled trial JAMA 300 4 2008 395 404
98. J. Carter, D. Goldfrank, and L.R. Schover Simple strategies for vaginal health promotion in cancer survivors J. Sex. Med. 8 2 2011 549 559
99. J. van der Laak, and et al. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry J. Clin. Pathol. 55 2002 446 451
100. J.P. Wu, S.L. Fielding, and K. Fiscella The effect of polycarbophil gel (Replens) on bacterial vaginosis: a pilot study Eur. J. Obstet. Gynecol. Reprod. Biol. 130 1 2007 132 136
101. M. Bygdeman, and M. Swahn Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women Maturitas 23 1996 259 263
102. J. Chen, and et al. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial J. Sex. Med. 10 6 2013 1575 1584
103. M. Ekin, and et al. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial Arch. Gynecol. Obstet. 283 3 2011 539 543
104. D. Constantino, and C. Guaraldi Effectivness and safety of vaginal suppositories for the treatment of vaginal atrophy in posmenopausal women: an open, non-controlled clinical trial Eur. Rev. Med. Pharmacol. Sci. 12 2008 411 416
105. D. Portman, and et al. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial Maturitas 78 2 2014 91 98
106. G.A. Bachmann, J.O. Komi, and G. Ospemifene Study Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study Menopause 17 3 2010 480 486
107. M.F. Goetsch, J.Y. Lim, and A.B. Caughey A Practical Solution for Dyspareunia in Breast Cancer Survivors: A Randomized Controlled Trial J. Clin. Oncol. 2015
108. D.D. Rahn, and et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review Obstet. Gynecol. 124 6 2014 1147 1156
109. J.A. Suckling, and et al. Local estrogen for vaginal atrophy in postmenopausal women Cochrane Database Syst. Rev. 4 2006 CD001500
110. J.E. Rossouw, and et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial J. Am. Med. Assoc. 288 3 2002 321 333
111. N.R. Shah, J. Borenstein, and R.W. Dubois Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis Menopause 12 6 2005 668 678
112. G.L. Anderson, and et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the women's health initiative randomised placebo-controlled trial Lancet Oncol. 13 5 2012 476 486
113. R.B. Lee, T.W. Burke, and R.C. Park Estrogen replacement therapy following treatment for stage I endometrial carcinoma Gynecol. Oncol. 36 1990 189 191
114. K.A. Suriano, and et al. Estrogen replacement therapy in endometrial cancer patients: a matched control study Obstet. Gynecol. 97 4 2001 555 560
115. R.R. Barakat, and et al. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a gynecologic oncology group study J. Clin. Oncol. 24 4 2006 587 592
116. T.P. Miles, and N. Johnson Vaginal dilator therapy for women receiving pelvic radiotherapy Cochrane Database Syst. Rev. 9 2014 CD007291
117. N. Johnson, T.P. Miles, and P. Cornes Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature BJOG 117 5 2010 522 531
118. L.C. Friedman, and et al. Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer Int. J. Radiat. Oncol. Biol. Phys. 80 3 2011 751 757
119. L. Lowenstein, and et al. Can stronger pelvic muscle floor improve sexual function? Int. Urogynecol. J. 21 5 2010 553 556
120. C. Goldfinger, and et al. A prospective study of pelvic floor physical therapy: pain and psychosexual outcomes in provoked vestibulodynia J. Sex. Med. 6 7 2009 1955 1968